
Mohamed Maher Al-Ghannam
HealthTechManaging Director & CEO, Avalon Pharma · Saudi Arabia
Joined Avalon Pharma in 2000 and has led it as CEO since 2018, taking the company to a listing on the Saudi Exchange in 2024. Avalon operates across 19 markets in the Middle East and Africa.







